Antineoplastic agents. 556. Isolation and structure of Coprinastatin 1 from Coprinus cinereus.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 2846224)

Published in J Nat Prod on March 26, 2010

Authors

George R Pettit1, Yanhui Meng, Robin K Pettit, Delbert L Herald, Zbigniew A Cichacz, Dennis L Doubek, Linda Richert

Author Affiliations

1: Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-1604, USA. bpettit@asu.edu

Articles cited by this

A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74

An empirical correction for absorption anisotropy. Acta Crystallogr A (1995) 94.58

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst (1991) 9.39

Fungal laccases - occurrence and properties. FEMS Microbiol Rev (2006) 3.99

The pharmacological potential of mushrooms. Evid Based Complement Alternat Med (2005) 3.97

Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) (2004) 1.32

Fungal secretomes--nature's toolbox for white biotechnology. Appl Microbiol Biotechnol (2008) 1.32

FOLy: an integrated database for the classification and functional annotation of fungal oxidoreductases potentially involved in the degradation of lignin and related aromatic compounds. Fungal Genet Biol (2008) 1.31

Molecular characterization, relatedness and antifungal susceptibility of the basidiomycetous Hormographiella species and Coprinus cinereus from clinical and environmental sources. Antonie Van Leeuwenhoek (1996) 1.29

Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1). J Nat Prod (2003) 1.15

The laccase multi-gene family in Coprinopsis cinerea has seventeen different members that divide into two distinct subfamilies. Curr Genet (2006) 1.10

Novel illudins from Coprinopsis episcopalis (syn. Coprinus episcopalis), and the distribution of illudin-like compounds among filamentous fungi. Mycol Res (2003) 1.02

Molecular characterization of laccase genes from the basidiomycete Coprinus cinereus and heterologous expression of the laccase lcc1. Appl Environ Microbiol (1999) 1.01

The marine product cephalostatin 1 activates an endoplasmic reticulum stress-specific and apoptosome-independent apoptotic signaling pathway. J Biol Chem (2006) 0.98

Heptemerones A-G, seven novel diterpenoids from Coprinus heptemerus: producing organism, fermentation, isolation and biological activities. J Antibiot (Tokyo) (2005) 0.96

Four illudane sesquiterpenes from Coprinopsis episcopalis. Phytochemistry (2004) 0.91

Highly oxidized cuparene-type sesquiterpenes from a mycelial culture of Flammulina velutipes. Phytochemistry (2000) 0.89

An expanded family of fungalysin extracellular metallopeptidases of Coprinopsis cinerea. Mycol Res (2007) 0.89

Development of an integrated enzymatic treatment system for phenolic waste streams. Environ Technol (2006) 0.79

Amino acid pool composition of the basidiomycete Coprinus cinereus. Can J Microbiol (2007) 0.78

Synthesis of 4-acetylbenzoxazolin-2(3H)-one reported from zea mays J Nat Prod (1998) 0.78

Articles by these authors

Antineoplastic agents. 520. Isolation and structure of irciniastatins A and B from the Indo-Pacific marine sponge Ircinia ramosa. J Med Chem (2004) 1.49

Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1). J Nat Prod (2003) 1.15

Antineoplastic agents. 570. Isolation and structure elucidation of bacillistatins 1 and 2 from a marine Bacillus silvestris. J Nat Prod (2009) 1.06

Antineoplastic agents. 511. Direct phosphorylation of phenpanstatin and pancratistatin. J Nat Prod (2004) 1.02

Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans-dihydronarciclasine. J Nat Prod (2006) 1.02

Antineoplastic agents. 485. Isolation and structure of cribrostatin 6, a dark blue cancer cell growth inhibitor from the marine sponge Cribrochalina sp. J Nat Prod (2003) 1.02

Antineoplastic agents. 380. Isolation and X-ray crystal structure determination of isoaaptamine from the Republic of Singapore Hymeniacidon sp. and conversion to the phosphate prodrug hystatin 1. J Nat Prod (2004) 1.00

Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate. J Med Chem (2002) 0.99

Antineoplastic agents 470. Absolute configuration of the marine sponge bromopyrrole agelastatin A. Oncol Res (2005) 0.98

Antineoplastic agents 491. Synthetic conversion of aaptamine to isoaaptamine, 9-demethylaaptamine, and 4-methylaaptamine. J Org Chem (2004) 0.97

Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,). J Nat Prod (2008) 0.97

Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41. J Med Chem (2005) 0.95

Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamine. J Med Chem (2004) 0.94

Antineoplastic agents. 529. Isolation and structure of nootkastatins 1 and 2 from the Alaskan yellow cedar Chamaecyparis nootkatensis. J Nat Prod (2004) 0.94

Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides. J Med Chem (2003) 0.92

Antineoplastic agents. 542. Isolation and structure of sesterstatin 6 from the Indian Ocean sponge Hyrtios erecta. J Nat Prod (2005) 0.90

Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms. Med Mycol (2007) 0.90

Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation. BMC Biotechnol (2010) 0.90

Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1). J Nat Prod (2005) 0.88

Antineoplastic agents. 550. Synthesis of 10b(s)-epipancratistatin from (+)-narciclasine. J Nat Prod (2007) 0.88

Antineoplastic Agents. 554. The manitoba bacterium Streptomyces sp. J Nat Prod (2006) 0.86

Antineoplastic agents. 553. The Texas grasshopper Brachystola magna. J Nat Prod (2005) 0.86

Antineoplastic agents 500. Narcistatin. J Nat Prod (2003) 0.85

Differential gene expression in auristatin PHE-treated Cryptococcus neoformans. Antimicrob Agents Chemother (2004) 0.85

Developing technology-enhanced active learning for medical education: challenges, solutions, and future directions. J Am Osteopath Assoc (2015) 0.85

Isolation of labradorins 1 and 2 from Pseudomonas syringae pv. coronafaciens. J Nat Prod (2002) 0.84

Antineoplastic agents. 561. Total synthesis of respirantin. J Nat Prod (2007) 0.81

Antineoplastic Agents. 510. Isolation and structure of dolastatin 19 from the Gulf of California sea hare Dolabella auricularia. J Nat Prod (2004) 0.81

Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans. Antimicrob Agents Chemother (2002) 0.81

In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin. Med Mycol (2005) 0.81

The cephalostatins. 21. Synthesis of bis-steroidal pyrazine rhamnosides (1). J Nat Prod (2011) 0.80

An efficient synthetic strategy for obtaining 4-methoxy carbon isotope labeled combretastatin A-4 phosphate and other Z-combretastatins. J Nat Prod (2010) 0.79

Antineoplastic agents. 534. isolation and structure of sansevistatins 1 and 2 from the African Sansevieria ehrenbergii. J Nat Prod (2005) 0.79

Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs. J Nat Prod (2012) 0.78

Antineoplastic agents 582. Part 1: Isolation and structure of a cyclobutane-type sesquiterpene cancer cell growth inhibitor from Coprinus cinereus (Coprinaceae). Bioorg Med Chem (2010) 0.77

Isolation and structure of pedilstatin from a republic of maldives Pedilanthus sp. J Nat Prod (2002) 0.77

Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies. J Nat Prod (2012) 0.77

Antineoplastic agents. 488. Isolation and structure of yukonin from a yukon territory fungus. J Nat Prod (2003) 0.77

Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene. J Nat Prod (2005) 0.76

Antineoplastic agents. 573. isolation and structure of papilistatin from the papilionid butterfly Byasa polyeuctes termessa. J Nat Prod (2010) 0.75

Isolation and structures of axistatins 1-3 from the Republic of Palau marine sponge Agelas axifera Hentschel . J Nat Prod (2013) 0.75

Antineoplastic agents. 560. Isolation and structure of kitastatin 1 from an Alaskan Kitasatospora sp. J Nat Prod (2007) 0.75

Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units. J Nat Prod (2011) 0.75

Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2. J Nat Prod (2009) 0.75

Isolation and structure of ruprechstyril from Ruprechtia tangarana. J Nat Prod (2003) 0.75

Isolation and structure of gustastatin from the Brazilian nut tree Gustavia hexapetala. J Nat Prod (2004) 0.75

Antineoplastic agents. 535. Isolation and structure of plakorstatins 1 and 2 from the Indo-Pacific sponge Plakortis nigra. J Nat Prod (2004) 0.75

Antineoplastic agents. 558. Ampelocissus sp. cancer cell growth inhibitory constituents. J Nat Prod (2008) 0.75

Antineoplastic agents 540. The Indian Gynandropsis gynandra (Capparidaceae). Oncol Res (2005) 0.75

Synthesis and X-ray crystal structure of the dolabellaauricularia peptide dolastatin 18. J Org Chem (2004) 0.75

Antineoplastic agents. 522. Hernandia peltata (Malaysia) and Hernandia nymphaeifolia (Republic of Maldives). J Nat Prod (2004) 0.75